1. Executive Summary
H.R. 4541 EARLY Act bill amends the Public Health Service Act by reauthorizing breast and cervical cancer education, awareness, and screening programs through fiscal year 2030 and fiscal year 2031 under the governing authority of the U.S. Department of Health and Human Services.
2. What This Bill Would Do
[Section 102 amends authorization timeframes for young women's breast health education programs. Currently, Section 399NN(h) of the Public Health Service Act authorizes appropriations through fiscal year 2026. This provision extends authorization of appropriations through fiscal year 2031.
Section 202(a)(1) modifies program requirements under the National Breast and Cervical Cancer Early Detection Program. Currently, 42 U.S.C. 300k mandates support services such as case management and sets specific focus areas. This provision requires programs to ensure appropriate follow-up services, adds prevention emphasis, expands support activities to include healthcare navigation, and mandates strategies to reduce health outcome disparities.
Section 202(a)(3) modifies reporting frequency to Congressional committees. Currently, 42 U.S.C. 300n-4(b) requires an annual report to Congress. This provision requires the first report 2 years after enactment, followed by reports every 5 years covering the preceding 5 fiscal years, and updates the committee reference to the Senate Committee on Health, Education, Labor, and Pensions.
Section 202(a)(4) authorizes funding levels for the National Breast and Cervical Cancer Early Detection Program. Currently, statutory authorizations under 42 U.S.C. 300n-5(a) reference fiscal year 2011. This provision authorizes $235,500,000 for each of fiscal years 2026 through 2030.
Section 202(b) mandates a study by the Government Accountability Office (GAO). Currently, no such specific GAO study is required for this cycle. This provision requires the Comptroller General to submit a report to House and Senate committees by September 30, 2027, analyzing eligible populations, service trends, and access barriers.
3. Who is Affected
Young Women / Patients Seeking Early Detection Services
If bill passes: Program authorization extends through 2031 for education and 2030 for screening access, with provisions prioritizing health navigation and barrier reduction.
If bill fails: Authorizations under existing program terms expire after fiscal year 2026.
Governing section: Section 102 and Section 202(a).
U.S. Department of Health and Human Services / CDC Grant Recipients
If bill passes: Grants require integration of screening navigation, focus on reducing population disparities, and modified reporting cycles.
If bill fails: Grant structures remain bound to annual reporting schedules and original scope requirements under 42 U.S.C. 300k.
Governing section: Section 202(a)(1)–(3).
Government Accountability Office (GAO)
If bill passes: Must complete and submit an evaluation report on program eligibility, trends, and access barriers to Senate HELP and House Energy and Commerce committees by September 30, 2027.
If bill fails: GAO carries no mandate under this bill to conduct or deliver this specific evaluation.
Governing section: Section 202(b).
4. Existing Law vs. What Would Change
Current Law or Condition | What This Bill Changes |
42 U.S.C. 280m(h): Authorizes Young Women's Breast Health Education and Awareness program through 2026. | Section 102 (Page 3, Line 13): Strikes "2026" and inserts "2031". |
42 U.S.C. 300k(a)(2): Requires "the provision of appropriate follow-up services and support services such as case management". | Section 202(a)(1)(A)(i) (Page 4, Line 18): Strikes language and inserts "that appropriate follow-up services are provided". |
42 U.S.C. 300k(a): Does not explicitly include target language for navigation activities or population disparity reduction. | Section 202(a)(1)(A)(vi) (Page 5, Line 1): Inserts paragraphs (6), (7), and (8) requiring navigation support and strategies to reduce incidence/mortality disparities. |
42 U.S.C. 300n-4(b): Requires reporting 1 year after 2007 reauthorization and annually thereafter. | Section 202(a)(3)(A) (Page 6, Line 13): Requires reporting 2 years after enactment, then every 5 years covering 5 fiscal year increments. |
42 U.S.C. 300n-5(a): Contains historical authorization figures ending in fiscal year 2011. | Section 202(a)(4)(B) (Page 7, Line 9): Inserts "$235,500,000 for each of fiscal years 2026 through 2030". |
5. Fiscal Impact Summary
No CBO score or official fiscal note is currently available for this legislation. Fiscal impact cells are left blank pending official scoring.
6. Household Impact Matrix
Analysis for a household earning $35,000 to $100,000 (Median range for rural Ohio/Appalachian communities).
Metric | If Bill Passes | If Bill Fails or Status Quo Continues |
Household Overhead | Insufficient primary source data — pending official analysis. | Continuation of current cost trajectory based on existing law and published projections. |
Market Stability | Insufficient primary source data — pending official analysis. | Documented risks or benefits of maintaining current regulatory environment. |
Mobility Check | Insufficient primary source data — pending official analysis. | Does current law contain documented dependency traps or mobility barriers that remain unchanged? |
Local Government Impact | Authorizes $235,500,000 annually (FY 2026–2030) for state/grantee screening programs. | Current funding levels and regulatory authority remain under existing law through FY 2026. |
7. Provisions Requiring Review
Section 202(a)(1)(A)(vi) (Page 5, Lines 6–10) delegates implementation parameters by requiring grantees to implement "evidence-based or evidence-informed strategies to increase breast and cervical cancer screening in health care settings" without defining qualifying thresholds for "evidence-informed". Verify against CDC administrative guidelines and federal regulations governing public health grant criteria.
Section 202(a)(1)(A)(vi) (Page 5, Lines 16–18) references "factors that relate to negative health outcomes" without defining specific clinical or socio-environmental metrics. Verify against HHS definitions or agency regulatory guidance.
8. What This Bill Does Not Do
The bill text does not contain provisions related to federal insurance coverage mandates or universal healthcare expansion. Public discussion has referenced healthcare coverage mandates in connection with this legislation. No such provision appears in H.R. 4541 as reported in the House.
The bill text does not contain provisions related to prescription drug pricing or pharmaceutical cost regulation. Public discussion has referenced cancer medication cost caps in connection with general cancer legislation. No such provision appears in H.R. 4541 as reported in the House.
The Ledger is Closed,
LegisLedger | Civic Intelligence. Clearly Delivered.
Legal Disclosures & Compliance Physical Address: LegisLedger Media LLC | [PO Box 284] | [Peebles, Ohio 45660]
Copyright: © 2026 LegisLedger. All rights reserved. No part of this publication may be reproduced or transmitted without express written permission.
Trademark: LegisLedger is a trademark of LegisLedger Media LLC. Trademark registration pending.
DMCA Notice: To report intellectual property infringement, please contact our designated agent at [[email protected]].
Privacy & Transparency You are receiving this because you opted in at [thelegisledger.org].
We value your data privacy; review our Privacy Policy and Terms of Service.
Keep the LegisLedger independent. We accept no lobbyist or corporate funding. If you value non-partisan data, consider supporting our mission: buymeacoffee.com/TheLegisLedger